Reuters logo
BRIEF-VBL Therapeutics announces completion of enrollment in the pivotal globe study
January 6, 2017 / 12:12 PM / 10 months ago

BRIEF-VBL Therapeutics announces completion of enrollment in the pivotal globe study

Jan 6 (Reuters) - Vascular Biogenics Ltd

* Announces completion of enrollment in the pivotal globe study

* Vascular Biogenics says continues to expect that pivotal globe study interim analysis will occur in mid-2017

* Says continues to expect top-line results from pivotal globe study full dataset will be available in early 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below